Corbus Pharmaceuticals Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 181.68 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 177.20K shares.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 4.48K shares.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 16.00K shares.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 16.00K shares, a 70.84% decline from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 54.88K shares, a 64.60% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 155.05K shares, a 176.77% increase from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 56.02K shares, a 69.33% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 177.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 181.68K shares 10-Q · filed 2026-08-06 | 197.68K shares derived: sum of 3 quarters · filed 2026-08-06 | 197.68K shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 4.48K shares 10-Q · filed 2026-05-12 | 20.48K shares derived: sum of 2 quarters · filed 2026-05-12 | 20.48K shares derived: sum of 3 quarters · filed 2026-05-12 | 20.48K shares derived: sum of 4 quarters · filed 2026-05-12 | |
| 2025-12-31 | 16.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 16.00K shares derived: sum of 2 quarters · filed 2026-03-09 | 16.00K shares derived: sum of 3 quarters · filed 2026-03-09 | 16.00K shares 10-K · filed 2026-03-09 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-12 | 0.00 shares 10-Q · filed 2025-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2025-11-12 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 0.00 shares 10-Q · filed 2025-08-05 | 0.00 shares derived: sum of 3 quarters · filed 2025-08-05 | 0.00 shares derived: sum of 4 quarters · filed 2025-08-05 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-06 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-06 | 0.00 shares derived: sum of 3 quarters · filed 2025-05-06 | 0.00 shares derived: sum of 4 quarters · filed 2025-05-06 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-11 | 0.00 shares derived: sum of 3 quarters · filed 2025-03-11 | 54.88K shares 10-K · filed 2025-03-11 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-07 | 54.88K shares 10-Q · filed 2024-11-07 | 82.07K shares derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 54.88K shares 10-Q · filed 2024-08-06 | 82.07K shares derived: sum of 3 quarters · filed 2024-08-06 | 89.02K shares derived: sum of 4 quarters · filed 2024-08-06 | |
| 2024-03-31 | 54.88K shares 10-Q · filed 2024-05-07 | 82.07K shares derived: sum of 2 quarters · filed 2024-05-07 | 89.02K shares derived: sum of 3 quarters · filed 2024-05-07 | 194.16K shares derived: sum of 4 quarters · filed 2024-05-07 | |
| 2023-12-31 | 27.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 34.14K shares derived: sum of 2 quarters · filed 2024-03-12 | 139.28K shares derived: sum of 3 quarters · filed 2024-03-12 | 155.05K shares 10-K · filed 2024-03-12 | |
| 2023-09-30 | 6.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 112.09K shares derived: sum of 2 quarters · filed 2023-11-07 | 127.85K shares 10-Q · filed 2023-11-07 | -1.22M shares derived: sum of 4 quarters · filed 2024-03-12 | |
| 2023-06-30 | 105.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 120.91K shares 10-Q · filed 2023-08-08 | -1.23M shares derived: sum of 3 quarters · filed 2024-03-12 | -665.31K shares derived: sum of 4 quarters · filed 2024-03-12 | |
| 2023-03-31 | 15.77K shares 10-Q · filed 2023-05-09 | -1.33M shares derived: sum of 2 quarters · filed 2024-03-12 | -770.45K shares derived: sum of 3 quarters · filed 2024-03-12 | -345.72K shares derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-12-31 | -1.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -786.22K shares derived: sum of 2 quarters · filed 2024-03-12 | -361.49K shares derived: sum of 3 quarters · filed 2024-03-12 | 56.02K shares 10-K · filed 2024-03-12 | |
| 2022-09-30 | 561.84K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 986.57K shares derived: sum of 2 quarters · filed 2022-11-08 | 1.40M shares 10-Q · filed 2022-11-08 | -1.40M shares derived: sum of 4 quarters · filed 2023-03-07 | |
| 2022-06-30 | 424.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 842.23K shares 10-Q · filed 2022-08-09 | -1.96M shares derived: sum of 3 quarters · filed 2023-03-07 | -563.13K shares derived: sum of 4 quarters · filed 2023-03-07 | |
| 2022-03-31 | 417.50K shares 10-Q · filed 2022-05-10 | -2.39M shares derived: sum of 2 quarters · filed 2023-03-07 | -987.85K shares derived: sum of 3 quarters · filed 2023-03-07 | -469.49K shares derived: sum of 4 quarters · filed 2023-03-07 | |
| 2021-12-31 | -2.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -1.41M shares derived: sum of 2 quarters · filed 2023-03-07 | -886.99K shares derived: sum of 3 quarters · filed 2023-03-07 | 182.66K shares 10-K · filed 2023-03-07 | 5.48M shares 10-K · filed 2022-03-08 |
| 2021-09-30 | 1.40M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 1.92M shares derived: sum of 2 quarters · filed 2021-11-12 | 2.99M shares 10-Q · filed 2021-11-12 | 5.27M shares derived: sum of 4 quarters · filed 2022-03-08 | |
| 2021-06-30 | 518.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 1.59M shares 10-Q · filed 2021-08-12 | 3.87M shares derived: sum of 3 quarters · filed 2022-03-08 | 4.10M shares derived: sum of 4 quarters · filed 2022-03-08 | |
| 2021-03-31 | 1.07M shares 10-Q · filed 2021-05-13 | 3.35M shares derived: sum of 2 quarters · filed 2022-03-08 | 3.58M shares derived: sum of 3 quarters · filed 2022-03-08 | 3.95M shares derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-12-31 | 2.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | 2.51M shares derived: sum of 2 quarters · filed 2022-03-08 | 2.88M shares derived: sum of 3 quarters · filed 2022-03-08 | 3.06M shares 10-K · filed 2022-03-08 | |
| 2020-09-30 | 227.72K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | 595.96K shares derived: sum of 2 quarters · filed 2020-11-09 | 782.53K shares 10-Q · filed 2020-11-09 | 853.05K shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-06-30 | 368.24K shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | 554.81K shares 10-Q/A · filed 2020-08-31 | 625.33K shares derived: sum of 3 quarters · filed 2021-03-15 | 712.85K shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2020-03-31 | 186.57K shares 10-Q · filed 2020-05-11 | 257.09K shares derived: sum of 2 quarters · filed 2021-03-15 | 344.61K shares derived: sum of 3 quarters · filed 2021-03-15 | 485.49K shares derived: sum of 4 quarters · filed 2021-03-15 | |
| 2019-12-31 | 70.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | 158.04K shares derived: sum of 2 quarters · filed 2021-03-15 | 298.92K shares derived: sum of 3 quarters · filed 2021-03-15 | 367.39K shares 10-K · filed 2021-03-15 | |
| 2019-09-30 | 87.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 228.40K shares derived: sum of 2 quarters · filed 2019-11-07 | 296.87K shares 10-Q · filed 2019-11-07 | 367.13K shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-06-30 | 140.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 209.35K shares 10-Q · filed 2019-08-08 | 279.61K shares derived: sum of 3 quarters · filed 2020-03-16 | 424.36K shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2019-03-31 | 68.48K shares 10-Q · filed 2019-05-09 | 138.73K shares derived: sum of 2 quarters · filed 2020-03-16 | 283.48K shares derived: sum of 3 quarters · filed 2020-03-16 | 518.47K shares derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-12-31 | 70.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 215.00K shares derived: sum of 2 quarters · filed 2020-03-16 | 449.99K shares derived: sum of 3 quarters · filed 2020-03-16 | 490.41K shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 144.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 379.74K shares derived: sum of 2 quarters · filed 2018-11-08 | 420.16K shares 10-Q · filed 2018-11-08 | 525.55K shares derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-06-30 | 234.99K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 275.41K shares 10-Q · filed 2018-08-08 | 380.80K shares derived: sum of 3 quarters · filed 2019-03-12 | ||
| 2018-03-31 | 40.42K shares 10-Q · filed 2018-05-10 | 145.81K shares derived: sum of 2 quarters · filed 2019-03-12 | |||
| 2017-12-31 | 105.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 173.98K shares 10-K · filed 2019-03-12 | |||
| 2017-09-30 | 68.58K shares 10-Q · filed 2017-11-08 | ||||
| 2016-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 556.00 shares derived: sum of 2 quarters · filed 2018-03-12 | 40.62K shares derived: sum of 3 quarters · filed 2018-03-12 | 65.00K shares 10-K · filed 2018-03-12 | |
| 2016-09-30 | -9.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 30.62K shares derived: sum of 2 quarters · filed 2016-11-10 | 55.00K shares 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 40.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | 64.44K shares 10-Q · filed 2016-08-12 | |||
| 2016-03-31 | 24.38K shares 10-Q · filed 2016-05-13 | ||||
| 2015-12-31 | 123.50K shares 10-K · filed 2017-03-08 | ||||
| 2013-12-31 | 3.40K shares 10-K · filed 2015-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |